
Just three months after Johnson had the ParaGard inserted, an ultrasound showed the IUD had migrated out of place in her uterus. Johnson’s doctor tried to extract the IUD but one arm broke off inside Johnson’s body. She underwent surgery in to remove the broken-off piece. According to her complaint, Johnson has suffered loss of reproductive health, pain, suffering, mental anguish and loss of enjoyment of life, and there’s the medical bills.
Four women in Missouri also claim they were injured when the ParaGard broke while doctors attempted to remove the device, reports KCUR.org. The women claim the companies knew or should have known that the ParaGard IUD is defective because its arms have a tendency to break upon removal from the uterus. According to their lawsuits, the FDA has received over 1,600 reports of ParaGuard breakage since 2010, with 700 classified as serious.
The global medical device company Cooper Surgical says on its website aimed at the health community that ParaGard IUD, with 1 hormone-free active ingredient (copper), “delivers the strongest combination of benefits for the widest range of women...Satisfy more patients with ParaGard—the only highly effective, reversible birth control that is completely hormone free.” It neglects to say that many lawsuits have been filed against it and the manufacturer Teva Pharmaceuticals from women who have suffered severe complications from the IUD.
Johnson told a New York federal court on August 31, 2020 that Teva:
- overstated the benefits of the ParaGard while downplaying the risks and failed to warn that it could break and injure her.
- knew or should have known about its defects based on trials, third-party studies, and consumer experience and complaints.
- deliberately hid the risks and defects of the ParaGard, and she only found out there were any such risks after the device broke while being removed.
The FDA and Paragard
READ MORE PARAGARD LEGAL NEWS
More ParaGard Lawsuits Expected
As of September 24, there are at least 55 actions pending in 29 different judicial districts, all claiming similar wrongful conduct on the part of CooperSurgical and Teva. Given the scope of ParaGard sales, plaintiffs’ attorney said that, “it is likely that hundreds of other actions will be filed in jurisdictions throughout the U.S.” ParaGard was purchased in November 2017 from Teva Pharmaceutical Industries Ltd., for approximately $1.1 billion.